546 related articles for article (PubMed ID: 30782609)
21. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
Maura F; Agnelli L; Leongamornlert D; Bolli N; Chan WC; Dodero A; Carniti C; Heavican TB; Pellegrinelli A; Pruneri G; Butler A; Bhosle SG; Chiappella A; Di Rocco A; Zinzani PL; Zaja F; Piva R; Inghirami G; Wang W; Palomero T; Iqbal J; Neri A; Campbell PJ; Corradini P
Am J Hematol; 2019 Jun; 94(6):628-634. PubMed ID: 30829413
[TBL] [Abstract][Full Text] [Related]
22. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
[TBL] [Abstract][Full Text] [Related]
23. Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Wilcox R; Naushad H; Rohr J; Heavican TB; Wang C; Bouska A; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):89-100. PubMed ID: 26319391
[TBL] [Abstract][Full Text] [Related]
24. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
[TBL] [Abstract][Full Text] [Related]
25. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
[TBL] [Abstract][Full Text] [Related]
26. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
[TBL] [Abstract][Full Text] [Related]
27. Expression of telomerase reverse transcriptase in peripheral T-cell lymphoma.
Arakawa F; Miyoshi H; Yoshida N; Nakashima K; Watatani Y; Furuta T; Yamada K; Moritsubo M; Takeuchi M; Yanagida E; Shimasaki Y; Kohno K; Kataoka K; Ohshima K
Cancer Med; 2021 Oct; 10(19):6786-6794. PubMed ID: 34477310
[TBL] [Abstract][Full Text] [Related]
28. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
[TBL] [Abstract][Full Text] [Related]
29. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
[TBL] [Abstract][Full Text] [Related]
30. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
Timmins MA; Wagner SD; Ahearne MJ
Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
[TBL] [Abstract][Full Text] [Related]
31. Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.
Sakata-Yanagimoto M; Fukumoto K; Karube K; Chiba S
J Clin Exp Hematop; 2021 Jun; 61(2):61-70. PubMed ID: 33716242
[TBL] [Abstract][Full Text] [Related]
32. Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma.
Lone W; Bouska A; Sharma S; Amador C; Saumyaranjan M; Herek TA; Heavican TB; Yu J; Lim ST; Ong CK; Slack GW; Savage KJ; Rosenwald A; Ott G; Cook JR; Feldman AL; Rimsza LM; McKeithan TW; Greiner TC; Weisenburger DD; Melle F; Motta G; Pileri S; Vose JM; Chan WC; Iqbal J
Clin Cancer Res; 2021 Nov; 27(21):6039-6053. PubMed ID: 34426436
[TBL] [Abstract][Full Text] [Related]
33. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
Paik JH; Koh J; Han B; Kim S; Lee KR; Lee S; Lee JO; Kim TM; Kim WY; Jeon YK
Hum Pathol; 2023 Jan; 131():47-60. PubMed ID: 36495942
[TBL] [Abstract][Full Text] [Related]
34. Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Review of Current Disease Understanding and Therapeutic Approaches.
Al-Zahrani M; Savage KJ
Hematol Oncol Clin North Am; 2017 Apr; 31(2):189-207. PubMed ID: 28340873
[TBL] [Abstract][Full Text] [Related]
35. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma.
Valleron W; Ysebaert L; Berquet L; Fataccioli V; Quelen C; Martin A; Parrens M; Lamant L; de Leval L; Gisselbrecht C; Gaulard P; Brousset P
Blood; 2012 Nov; 120(19):3997-4005. PubMed ID: 22990019
[TBL] [Abstract][Full Text] [Related]
36. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
[TBL] [Abstract][Full Text] [Related]
37. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
[TBL] [Abstract][Full Text] [Related]
38. Clonal haematopoiesis: A common progenitor for cytotoxic peripheral T-cell lymphoma and angioimmunoblastic T-cell lymphoma.
Vogelsberg A; Harland L; Borgmann V; Otto F; Weller JF; Nann D; Quintanilla-Martinez L; Fend F
Br J Haematol; 2024 May; 204(5):2071-2076. PubMed ID: 38323682
[TBL] [Abstract][Full Text] [Related]
39. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
Martín García-Sancho A; Rodríguez-Pinilla SM; Domingo-Domenech E; Climent F; Sánchez-Garcia J; López Jiménez J; García-Cosío Piqueras M; Castellvi J; González AJ; González de Villambrosia S; Gómez Codina J; Navarro B; Rodríguez G; Borrero JJ; Fraga M; Naves A; Baeza L; Córdoba R
Br J Haematol; 2023 Oct; 203(2):182-193. PubMed ID: 37386897
[TBL] [Abstract][Full Text] [Related]
40. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]